Conference on Pharmaceutical Pricing Practices, Utilization, and Costs
August 8th & 9th
Dr. Margarget A. Hamburg's Opening Remarks
Projections of Drug Approvals, Patent Expirations, and Generic Entry from 2000 to 2004 by C. Daniel Mullins, Ph.D., Francis Palumbo, Ph.D., J.D., & Bruce Stuart, Ph.D. -- FINAL
Factors Driving Pharmaceutical Expenditures: An Overview by Ernst R. Berndt, Ph.D. -- FINAL
Explaining the Growth in Prescription Drug Spending: A Review of Recent Studies by Mark Merlis, M.A. -- FINAL
Prescription Drug Coverage, Spending, Utilization and Prices by Jack Hoadley, Ph.D.
Pharmaceutical Pricing: Practices & Issues by Robert A. Freeman, Ph.D. -- FINAL
Pricing Mechanisms Used by the Federal Government to Contain Prescription Drug Costs by Anna Cook, Ph.D. -- FINAL
Drug Utilization Trends by Therapeutic Class by Cindy Parks Thomas, Ph.D. and Grant Ritter, Ph.D. -- FINAL
Medicare Beneficiaries: Prescription Drug Utilization Trends by John Poisal -- FINAL
Medication Decisions-Right and Wrong by Bruce Stuart, Ph.D. and Becky Briesacher, M.A. -- FINAL
FDA's Research About Consumer-Directed Prescription Drug Program by Nancy M. Ostrove, Ph.D. -- FINAL
Cost Control for Prescription Drug Programs: Pharmacy Benefit Manager PBM Efforts, Effects, and Implication by David H. Kreling, Ph.D., R.Ph. -- FINAL
Role of Price Transparency in the Pharmaceutical Market by Stephen W. Schondelmeyer, Pharm.D., Ph.D. -- FINAL
Managing the Unmanageable: Drug Payment and Utilization Management Strategies in Physician Organizations by Helene Levens Lipton, Ph.D. -- FINAL
Price Trends for Prescription Pharmaceuticals: 1995-1999 by Joseph A. DiMasi, Ph.D. -- FINAL
Why Different Purchasers Pay Different Prices for Prescription Drugs by Anna Cook -- FINAL